nct02637284 bpc-157 trial results – No Proof Required! | Office for Science and Society Multifunctionality and Possible Medical Application

In a review published last year, Sikiric and his colleagues describe BPC-157 as a drug like no other: In animal models, it counteracts symptoms akin to those of Parkinsons, Alzheimers, and schizophrenia

A., Wibowo, E., Johnson, T

These systemic adaptations reflect the broad distribution of P4 receptors across multiple tissues, including the central nervous system, liver, skeletal muscle, adipose tissue, and gastrointestinal tract

Compound: BPC-157 + TB-500 co-lyophilised blend

Direct FGF-2 Gene Transfer via Recombinant Adeno-Associated Virus Vectors Stimulates Cell Proliferation, Collagen Production, and the Repair of Experimental Lesions in the Human ACL

Its common to have slight pain, tenderness, swelling, or redness at the injection site